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 Orskov and colleagues 1 (this issue) and 
the Danish government are commended 
for increasing our understanding of the 
factors associated with risk for progres-
sion of renal disease in autosomal domi-
nant polycystic kidney disease (ADPKD). 
The carefully performed analyses of 
Orskov  et al. 1 provide the key observation 
that lower birth weight associates with an 
earlier age of onset of end-stage renal dis-
ease (ESRD) in ADPKD. Diligent investi-
gative work and the availability of accurate, 
complete, and validated medical archival 
data from the Danish State Archives, the 
Danish National Registry of Dialysis and 
Transplantation, the Danish Data Protec-
tion Agency, and the Danish Nephrology 
Practice Groups were able to provide two 
decades of longitudinal information from 
more than 95 % of diagnosed ADPKD 
patients in Denmark. 
 The association between a kilogram 
increase in birth weight and an increase in 
age of onset of ESRD of 1.7 years is further 
support for the hypothesis put forward by 
Barker more than 50 years ago, indicating 
that the fetal environment contributes to 
the development of a variety of chronic 
adult diseases. 2 Previous investigators have 
demonstrated an association between birth 
weight and the development of the meta-
bolic syndrome, and age of onset of ESRD 
in type 2 diabetes, IgA nephropathy, and 
minimal-change disease. 1 Brenner and 
colleagues have carried the Barker para-
digm forward and established the impor-
tance of the placental or intrauterine 
environment with regard to the determina-
tion of terminal nephron number, glomer-
ular size, and salt sensitivity in humans. 3 
 ADPKD is a hereditary renal disorder in 
which renal failure typically does not occur 
until the fi ft h or sixth decade of life. Post-
natal epigenetic and environmental factors 
play a signifi cant role in the progression 
to renal failure in this disease. 4 As Orskov 
 et al. 1 now show, the intrauterine environ-
ment signifi cantly impacts the severity of 
ADPKD through determination of birth 
weight. Adequate polycystin levels are 
critical for normal fetal kidney develop-
ment. Under normal conditions, polycystin 
activity is upregulated during embryogen-
esis at specifi c phases of renal development. 
Also, under normal conditions, polycystin 
activity increases in response to ischemia 
reperfusion injury. If polycystin concentra-
tions are low, as occurs in ADPKD, cyst 
formation rather than normal renal tubule 
development takes place. If ischemia or 
reduced placental blood flow is also 
present, activation of the renin-angi-
otensin-aldosterone system and increases 
in vasopressin levels occur, potentially aug-
menting cyst formation and growth. 
 Intracellular cyclic adenosine mono-
phosphate (ic cAMP) levels are increased 
in cystic epithelial cells and impact both 
proliferative and secretory aspects of cyst 
formation and growth in ADPKD. Vaso-
pressin availability and action augments ic 
cAMP levels and cyst growth in ADPKD. 
Reduced vasopressin action is associated 
with reduced disease severity in a variety 
of different renal cystic disease models 
of ADPKD. When intrauterine growth 
retardation occurs and during the obligate 
process of birth through labor and deli-
very, vasopressin levels increase signifi -
cantly in both amniotic fl uid and the fetal 
circulation. Whether these increases in 
fetal vasopressin levels translate to 
increases in fetal renal tubular epithelial ic 
cAMP levels and more robust and earlier 
renal cyst development in ADPKD is not 
yet known. 5 
 Important to consider in current day 
conditions, infants “behind” in growth at 
the time of birth, have an accelerated 
growth rate post-natally. Post-natal growth 
may be important for programming pre-
disposing to adult diseases as well. Rele-
vant to ADPKD, the insulin like growth 
factor-I system is important in post-natal 
growth and mediates epithelial cell proli-
feration in polycystic kidney disease. 
 As described by other investigators, 
reduced birth weight at a threshold of less 
than 2500  g associates with a reduced 
number of nephrons at birth, an increase 
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 Orskov and colleagues demonstrate the impact of birth weight on the mean 
age of end-stage renal disease (ESRD) in a large Danish ADPKD cohort. Each 
kilogram of birth weight extended the mean age of ESRD onset by 1.7 years. 
Placental insufficiency, activation of the renin-angiotensin-aldosterone 
system, increased fetal vasopressin levels, compensatory increases in 
insulin like growth factor-I, and a reduction in total nephron number may 
all contribute to this observation. Collectively, these changes result in an 
accelerated pace of cyst formation and expansion, and an inability to 
maintain glomerular hyperfiltration during kidney expansion which results 
in a more rapid progression to ESRD. Therefore the intrauterine 
environment may play a critical role in disease severity in ADPKD. 
 Kidney International (2012)  81, 814 – 815.  doi: 10.1038/ki.2012.8 
 1 Emory University School of Medicine, Clinical 
Interaction Network ,  Atlanta ,  Georgia ,  USA 
 Correspondence: Arlene B. Chapman, Emory 
University School of Medicine, Clinical Interaction 
Network, 1364 Clifton Road, Atlanta, Georgia 
30322, USA. 
E-mail:  arlene.chapman@emoryhealthcare.org 
see original article on page 919
commentar y
Kidney International (2012) 81     815
in glomerular size, and glomerular hyper-
filtration. Recently, available evidence 
from a number of observational cohorts 
suggests why reduced nephron number 
and glomerular hyperfi ltration may be 
particularly devastating to patients with 
ADPKD with regard to risk for progres-
sion to ESRD. Data from observational 
registries indicate that cyst formation and 
expansion forecasts future renal failure in 
ADPKD. 6 Through standardized and 
validated magnetic resonance image 
acquisitions, the Consortium for Radio-
logic Imaging in Polycystic Kidney Dis-
ease (CRISP), the SUISSE cohort and the 
pediatric ADPKD cohort at the University 
of Colorado show that growth and expan-
sion renal cysts result in an increase in 
total kidney volume (TKV) in the vast 
majority of ADPKD individuals, detect-
able within a relatively short period or 
time (six months), over decades prior 
to loss of kidney function. 7 – 9 Importantly, 
in both animal and human microdissec-
tion studies, renal cyst growth in ADPKD 
is focal, affecting fewer than 5 % of all 
nephrons. Therefore, the significant 
focal cyst expansion that takes place in 
ADPKD is suffi  cient to result in massive 
kidney enlargement, with most end-stage 
kidneys weighing more than 8  kg. The 
ability to maintain normal renal function 
through incompletely understood mecha-
nisms of glomerular hyperfiltration 
is required in ADPKD patients during 
the decades of continuous cyst and 
renal growth. If one were to have fewer 
nephrons overall, due to low birth weight, 
the adaptive glomerular hyperfi ltration 
needed to maintain normal kidney func-
tion during the periods of signifi cant cyst 
growth and expansion in the fi rst four 
decades of life would be lost. 
 Finally, evidence suggests that there are 
specifi ed periods of accelerated cyst growth 
in ADPKD that may include the pre-natal 
period. 1,3 Children with ADPKD demon-
strate a greater rate of increase in TKV 
than adults (9.0 vs. 5.7 % per year). 10,11 
Mathematical modeling of the TKV 
growth curves measured in adult CRISP 
participants predict rate of cyst growth and 
expansion prior to enrollment in the 
CRISP study at least fourfold greater than 
measured during CRISP. 12 In addition, 
these modeling experiments indicate that 
the majority of cysts responsible for the 
TKV measured in CRISP occur extremely 
early, close to the time of birth. 12 Th ese 
observations show that there are critical 
times of accelerated cyst growth that link 
to disease severity in ADPKD. Th erefore, 
in this context it is not surprising that the 
intrauterine environment manifested as 
birth weight is important in determining 
renal outcomes in this disorder. 
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